Dr. Jeffrey Sundstrom
Location
Areas of Expertise
About Me
Dr. Jeffrey Michael Sundstrom, MD, PhD is an Associate Professor of Ophthalmology at the Hospital of the University of Pennsylvania and a Penn Medicine physician specializing in ophthalmology with a focus on retinal diseases. He is board certified in ophthalmology and accepts new patients of all ages, providing care at the Scheie Eye Institute. His clinical expertise encompasses a wide range of retinal conditions, leveraging his research background to offer advanced diagnostic and therapeutic options.
Dr. Sundstrom manages complex eye conditions such as age-related macular degeneration, diabetic retinopathy, retinal detachment, and inherited retinal diseases. He performs specialized examinations including diabetic eye exams and uses spectral domain optical coherence tomography for precise imaging. His practice is dedicated to preserving vision and addressing both common and rare retinal disorders through evidence-based approaches.
In addition to his clinical work, Dr. Sundstrom is actively involved in research, investigating vitreous proteomics, extracellular vesicles, and molecular mechanisms in diabetic retinopathy and ocular diseases. His contributions to scientific literature aim to improve understanding and treatment of retinal conditions, integrating laboratory discoveries with patient care.
Training

University of Michigan
Fellowship
Penn State College of Medicine
Residency
Medical School
Penn State University
Medical School
Publications & Press
Diagnostic and Therapeutic Utility of Extracellular Vesicles in Ocular Disease
International Journal of Molecular Sciences•2025Sodium Iodate Induces Hyperreflective Foci in the Mouse Neural Retina
Frontiers in Bioscience Landmark•2024Investigating Vitreous Cytokines in Choroidal Melanoma
Cancers (Basel)•2023A validated analysis pipeline for mass spectrometry-based vitreous proteomics: new insights into proliferative diabetic retinopathy
Clin Proteomics•2021Proteomic Analyses of Vitreous in Proliferative Diabetic Retinopathy: Prior Studies and Future Outlook
J Clin Med•2021Expression of R345W-Fibulin-3 Induces Epithelial-Mesenchymal Transition in Retinal Pigment Epithelial Cells
Front Cell Dev Biol•2020Role of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelium Dysfunction
Front Cell Dev Biol•2020Liquid Biopsy of Vitreous Reveals an Abundant Vesicle Population Consistent With the Size and Morphology of Exosomes
Transl Vis Sci Technol•2018A proposal for early and personalized treatment of diabetic retinopathy based on clinical pathophysiology and molecular phenotyping
Vision Res•2017
Certifications & Licensure
- Licensed In
- PA
- License Numbers
- MD450629


